Offer - Urjas Oil for just ₹ 1 X
Mycurit 4 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Tuberculosis are some of its major therapeutic uses.
The optimal dosage of Mycurit 4 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Mycurit 4 Tablet include Dizziness, Difficulty breathing, Difficulty talking. These side effects of Mycurit 4 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Mycurit 4 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Mycurit 4 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Mycurit 4 Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Heart Disease as it can result in adverse effects. Some other conditions that can be affected by Mycurit 4 Tablet are listed in the contraindications section below.
Additionally, Mycurit 4 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mycurit 4 Tablet is considered not safe while driving, and is not addictive.
Mycurit 4 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mycurit 4 Tablet safe for pregnant women?
Mycurit may have some side effects during pregnancy. Pregnant women should discontinue the use of Mycurit, and talk to their doctor, if they notice any discomfort.
Is the use of Mycurit 4 Tablet safe during breastfeeding?
Mycurit can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mycurit 4 Tablet on the Kidneys?
Mycurit may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mycurit 4 Tablet on the Liver?
The liver can be affected by Mycurit. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mycurit only after medical advice.
What is the effect of Mycurit 4 Tablet on the Heart?
Mycurit can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Mycurit 4 Tablet unless your doctor advises you to do so -
Is this Mycurit 4 Tablet habit forming or addictive?
Mycurit 4 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mycurit 4 Tablet can make you feel drowsy.
Is it safe?
Mycurit 4 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Mycurit 4 Tablet for mental disorders.
Interaction between Food and Mycurit 4 Tablet
You can take Mycurit 4 Tablet with food.
Interaction between Alcohol and Mycurit 4 Tablet
Consumption of alcohol and Mycurit 4 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited